NCT04229381
- Conditions
- Advanced Lung Carcinoma, Extensive Stage Lung Small Cell Carcinoma, Lung Diseases, +13 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Stage IV Lung Cancer AJCC v8
Explore clinical trials studying Stage IV Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
123 public trials
44 recruiting studies
Stage IV Lung Cancer AJCC v8 trial results
NCT04662645
- Conditions
- Caregiver, Hemic and Lymphatic Diseases, Lung Diseases, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05342571
- Conditions
- Advanced Lung Carcinoma, Lung Diseases, Lung Neoplasms, +9 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03902535
- Conditions
- Caregiver, Head and Neck Carcinoma, Lung Carcinoma, +25 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
NCT00862680
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
NCT04340882
- Conditions
- Lung Diseases, Lung Neoplasms, Metastatic Non-Small Lung Cell Cancer, +9 more
- Locations
-
- Grady Health System Atlanta, Georgia, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
Active, Not Recruiting
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
NCT02971501
- Conditions
- Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +16 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Active, Not Recruiting
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
NCT04310007
- Conditions
- Lung Diseases, Lung Neoplasms, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, +7 more
- Locations
-
- Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
NCT05334329
- Conditions
- Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
- Locations
-
- Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States
Active, Not Recruiting
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced
NCT03225664
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- M D Anderson Cancer Center Houston, Texas, United States